|
NUDCD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.27280416709164E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.55799997745032E-09 |
| Normal-vs-Stage2 |
1.97825999999068E-05 |
| Normal-vs-Stage3 |
7.07219838247397E-11 |
| Normal-vs-Stage4 |
4.82350004382681E-09 |
| Stage1-vs-Stage2 |
5.814400E-01 |
| Stage1-vs-Stage3 |
4.584100E-02 |
| Stage1-vs-Stage4 |
6.937500E-02 |
| Stage2-vs-Stage3 |
4.330200E-01 |
| Stage2-vs-Stage4 |
3.776000E-01 |
| Stage3-vs-Stage4 |
7.733200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.37159991434544E-10 |
| Normal-vs-AfricanAmerican |
5.970200E-04 |
| Normal-vs-Asian |
1.16930000004789E-06 |
| Caucasian-vs-AfricanAmerican |
7.028600E-01 |
| Caucasian-vs-Asian |
8.576200E-01 |
| AfricanAmerican-vs-Asian |
6.289000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.81270004456979E-09 |
| Normal-vs-Female |
7.24039717070468E-11 |
| Male-vs-Female |
2.988800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.62939999948497E-07 |
| Normal-vs-Age(41-60Yrs) |
4.02540223376491E-11 |
| Normal-vs-Age(61-80Yrs) |
7.260699819156E-10 |
| Normal-vs-Age(81-100Yrs) |
5.618000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.489800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.155900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.359000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.629200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.665800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.772000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.035050E-01 |
| Classical-VS-Follicular |
8.625400E-04 |
| Classical-VS-Other |
6.169000E-01 |
| Classical-VS-Normal |
5.82079995314899E-09 |
| Tall-VS-Follicular |
6.149000E-01 |
| Tall-VS-Other |
3.949000E-01 |
| Tall-VS-Normal |
1.12259999995867E-06 |
| Follicular-VS-Other |
3.265800E-01 |
| Follicular-VS-Normal |
8.59470272729368E-11 |
| Other-VS-Normal |
5.430200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.71342972932598E-12 |
| Normal-vs-N1 |
4.01099999991494E-07 |
| N0-vs-N1 |
9.856400E-01 |
|
|
